MoonLake Immunotherapeutics (NASDAQ: MLTX) is under investigation by the DJS Law Group for possible securities fraud. The October 6, 2025, announcement has raised concerns among investors about potential violations of federal securities laws.

Jasper Therapeutics, Inc. is under legal scrutiny following a class action lawsuit filed by DJS Law Group. The case alleges the company violated key provisions of the Securities Exchange Act, potentially impacting the rights and investments of shareholders.